Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRHa after myomectomy for prevention of recurrence of multiple uterine fibroids
ChiCTR-IPR-17012992Phase 4Completed
- Sponsor
- Huazhong University of Science and Technology
- Start
- Jan 2018
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of triptorelin in Fibromyoma (LM) (2 arms), sponsored by Huazhong University of Science and Technology. Primary endpoints: Time to recurrence of uterine fibroids and Recurrence rate of uterine fibroids. Started Jan 2018; status: completed.
02
Drugs
triptorelin
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on ChiCTR-IPR-17012992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012992.